Literature DB >> 12384427

Regulation of thymic epithelium by keratinocyte growth factor.

Matthew Erickson1, Stanislaw Morkowski, Sophie Lehar, Geoffrey Gillard, Courtney Beers, James Dooley, Jeffrey S Rubin, Alexander Rudensky, Andrew G Farr.   

Abstract

Here we demonstrate that keratinocyte growth factor (KGF) and FGFR2IIIb signaling can affect development and function of thymic epithelium (TE) and that alphabeta-lineage thymocytes contribute to intrathymic levels of KGF. Thymocyte expression of KGF is developmentally regulated, being undetectable in CD3-4-8- thymocytes and expressed at highest levels by mature CD4 or CD8 thymocytes. Exposure of thymocyte-depleted fetal thymic lobes to KGF resulted in reduced thymic epithelial expression of class II major histocompatibility complex (MHC), invariant chain (Ii), and cathepsin L (CatL) molecules involved in thymocyte-positive selection and also stimulated expression of the cytokines interleukin 6 (IL-6) and thymic stromal-derived lymphopoietin (TSLP), while having little effect on IL-7 or stem cell factor expression. Within intact fetal thymic organ culture (FTOC), exogenous KGF impairs the generation of CD4 thymocytes. Two lines of evidence point to responsiveness of the medullary TE compartment to KGF and FGFR2IIIb signaling. First, the medullary compartment is expanded in intact FTOC exposed to KGF in vitro. Second, in the RAG-deficient thymus, where the thymocytes do not express detectable levels of KGF message, the hypoplastic medullary TE compartment can be expanded by administration of recombinant KGF in vivo. This expansion is accompanied by restoration of the normal profile of medullary TE-associated chemokine expression in the RAG2(-/-) thymus. Collectively, these findings point to a role for KGF and FGFR signaling in the development and function of thymic epithelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384427     DOI: 10.1182/blood-2002-04-1036

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

Review 1.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

Review 2.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

3.  Thymic stromal lymphopoietin is not necessary or sufficient to mediate the thymopoietic effects of keratinocyte growth factor.

Authors:  Martin Guimond; Warren J Leonard; Rosanne Spolski; Simona W Rossi; Rachelle G Veenstra; Georg A Hollander; Crystal L Mackall; Bruce R Blazar
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 4.  Clinical strategies to enhance posttransplant immune reconstitution.

Authors:  Irwin D Bernstein; Richard L Boyd; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 5.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

Review 6.  Thymic rejuvenation and aging.

Authors:  Melissa S Ventevogel; Gregory D Sempowski
Journal:  Curr Opin Immunol       Date:  2013-07-04       Impact factor: 7.486

Review 7.  Thymus involution and regeneration: two sides of the same coin?

Authors:  Thomas Boehm; Jeremy B Swann
Journal:  Nat Rev Immunol       Date:  2013-09-20       Impact factor: 53.106

8.  A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

Authors:  Jeffrey M Jacobson; Hongying Wang; Rebeka Bordi; Lu Zheng; Barry H Gross; Alan L Landay; John Spritzler; Jean-Pierre Routy; Constance Benson; Judith Aberg; Pablo Tebas; David W Haas; Jennifer Tiu; Kristine Coughlin; Lynette Purdue; Rafick-Pierre Sekaly
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

9.  Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.

Authors:  Ryan M Kelly; Emily M Goren; Patricia A Taylor; Scott N Mueller; Heather E Stefanski; Mark J Osborn; Hamish S Scott; Elena A Komarova; Andrei V Gudkov; Georg A Holländer; Bruce R Blazar
Journal:  Blood       Date:  2009-12-04       Impact factor: 22.113

Review 10.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.